Sekisui Chemical To Acquire U.S. CRO XenoTech
This article was originally published in PharmAsia News
Executive Summary
TOKYO - In an effort to expand its U.S. presence in preclinical services, Sekisui Chemical Co. says it plans to acquire Kansas-based contract research organization XenoTech in an undisclosed, all-cash transaction by the end of July